Zobrazeno 1 - 10
of 142
pro vyhledávání: '"John R. Lever"'
Autor:
Dennis K. Miller, Eric S. Park, Susan Z. Lever, Matthew J. Will, Melissa A. Tapia, John R. Lever
Publikováno v:
Psychopharmacology. 236:3147-3158
Previous research indicates that the selective sigma-1 receptor ligand PD144418 and the selective sigma-2 ligands YUN-252 can inhibit cocaine-induced hyperactivity. The effects of these ligands on other stimulants, such as methamphetamine, have not b
Publikováno v:
Pharmacological Research. 142:87-100
ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax) are under intensive preclinical and clinical investigation as treatments for hematologic and other malignancies. These small molecules mimic pro-death B-cell lymphoma-2 (Bcl-2) Homology 3 (BH3) d
Autor:
Fabio Gallazzi, Lisa D. Watkinson, Emily A. Fergason-Cantrell, Terry L. Carmack, John R. Lever
Publikováno v:
Nuclear Medicine and Biology. 70:53-66
Introduction Peripheral mu (μ) opioid receptors are implicated in pain, bowel dysfunction and the progression of certain cancers. In an effort to identify radioligands well suited for imaging these peripheral sites, we have prepared and evaluated fo
Autor:
Akula Bala Pramod, John R. Lever, Danielle Krout, L. Keith Henry, Michael J. Tomlinson, Roxanne A. Vaughan, Amy Hauck Newman
Publikováno v:
Neurochemistry International. 123:34-45
The dopamine transporter (DAT) is a neuronal membrane protein that is responsible for reuptake of dopamine (DA) from the synapse and functions as a major determinant in control of DA neurotransmission. Cocaine and many psychostimulant drugs bind to D
Autor:
Danielle Krout, Akula Bala Pramod, Michael J. Tomlinson, James D. Foster, Rejwi Acharya Dahal, Mu Fa Zou, John R. Lever, L. Keith Henry, Comfort Boatang, Roxanne A. Vaughan, Amy Hauck Newman, Babita Sharma
Publikováno v:
Biochem Pharmacol
Dopamine transporter (DAT) blockers like cocaine and many other abused and therapeutic drugs bind and stabilize an inactive form of the transporter inhibiting reuptake of extracellular dopamine (DA). The resulting increases in DA lead to the ability
Autor:
Dennis K. Miller, John R. Lever, Emma I. Fullerton, Melissa A. Tapia, Paige C. Hildebrant, Matthew J. Will, Susan Z. Lever, Andrew S. Sage, Jessica M. Judd
Publikováno v:
Psychopharmacology. 237(3)
The N-phenylpropyl-N′-substituted piperazines SA-4503 (N-phenylpropyl-N′-(3,4-dimethoxyphenethyl)piperazine) and YZ-185 (N-phenylpropyl-N′-(3-methoxyphenethyl)piperazine) bind to sigma (σ) receptors and block the development of cocaine-induced
Autor:
Melissa A, Tapia, John R, Lever, Susan Z, Lever, Matthew J, Will, Eric S, Park, Dennis K, Miller
Publikováno v:
Psychopharmacology. 236(11)
Previous research indicates that the selective sigma-1 receptor ligand PD144418 and the selective sigma-2 ligands YUN-252 can inhibit cocaine-induced hyperactivity. The effects of these ligands on other stimulants, such as methamphetamine, have not b
Publikováno v:
Tetrahedron. 72:6127-6135
Radiolabeled diprenorphine (DPN) and analogs are widely used ligands for non-invasive brain imaging of opioid receptors. To develop complementary radioligands optimized for studies of the peripheral opioid receptors, we prepared a pair of hydrophilic
Autor:
Terry L. Carmack, John R. Lever, Emily A. Fergason-Cantrell, Dennis K. Miller, Lisa D. Watkinson, Susan Z. Lever, Sarah A. Lord, Rong Xu
Publikováno v:
Synapse. 70:98-111
Activation of sigma1 (σ1) receptors contributes to the behavioral and toxic effects of (-)-cocaine. We studied a key step, the ability of (-)-cocaine to occupy σ1 receptors in vivo, using CD-1(®) mice and the novel radioligand [(125) I]E-N-1-(3'-i
Autor:
John R, Lever, Emily A, Fergason-Cantrell, Terry L, Carmack, Lisa D, Watkinson, Fabio, Gallazzi
Publikováno v:
Nuclear medicine and biology. 70
INTRODUCTION: Peripheral mu (μ) opioid receptors are implicated in pain, bowel dysfunction and the progression of certain cancers. In an effort to identify radioligands well suited for imaging these peripheral sites, we have prepared and evaluated f